Fortress Biotech 株価情報 (NASDAQ: FBIO)

Fortress Biotech (NASDAQ:FBIO) 株価情報

FORTRESS BIOTECH INC

Fortress Biotech

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Fortress Biotech Inc

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Cybersecurity firm DTEX has compared North Korea&#8217;s cybercrime operations to a mafia organization controlled by Kim Jong Un. The operations involve a global network of North Korean technologists who infiltrate Fortune 500 companies and launder money to support Kim&#8217;s nuclear and ballistic missile ambitions.
What Happened: North Korea has intensified its strategy this year by enlisting 90 top graduates for an AI research center, while also requiring them to hand over twice their monthly earnings. This development coincides with efforts towards laundering $1.5 billion stolen in a cryptocurrency exchange hack earlier this year, <a href="https://reports.dtexsystems.com/DTEX-Exposing+DPRK+Cyber+Syndicate+and+Hidden+IT+Workforce.pdf?_gl=1&#x2A;16ngf3n&#x2A;_gcl_aw&#x2A;R0NMLjE3NDY0NzEwMjQuQ2owS0NRand0OHpBQmhES0FSSXNBSFh1RDdaT1FkeS1SWTRXbDZVZHU4a2JCZHpVR0stNmlLRy1Lakh1Y3RnbkJYREdCQ2ZnamNtbGlfZ2FBakUxRUFMd193Y0I.&#x2A;_gcl_au&#x2A;OTYxMjM2ODE2LjE3NDQwNjkwNzE.">revealed </a>the report.
These IT workers, who are part of the regime's cyber cartel, collaborate with malicious North Korean Advanced Persistent Threat (APT) groups linked to the Korean People's Army. According to UN estimates, the IT workers generate between $250 million and $600 million annually, while the APTs have stolen at least $3 billion in cryptocurrency.
Many of these IT workers and APT actors, having trained together at elite institutions such as Kim Sung Il Military University and Kumsong Academy, are familiar with one another. This network of operatives, referred to as a "bro network," is a crucial part of the cybercrime operations.
The report highlights that North Korean workers are forced to compete under brutal conditions—working up to 16 hours a day, six days a week—with minimal breaks. They keep less than 20% of their earnings and must cover costs for operations and equipment themselves, while the main beneficiaries are Kim Jong Un's family and the North Korean elite.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45485070/the-stock-market-is-shooting-through-the-roof-says-dave-ramsey-but-claims-the-medias-silent-they-want-you-ad" target="_blank" rel="noreferrer noopener">&#8216;The Stock Market Is Shooting Through The Roof,&#8217; Says Dave Ramsey. But Claims The Media&#8217;s Silent—&#8217;They Want You Addicted To Fear&#8217;</a>
Why It Matters: Earlier this year, it was reported that thousands of North Korean IT workers were impersonating Americans to land jobs at Fortune 500 companies, with their earnings being used to fund Kim Jong Un‘s illicit weapons programs. They were leveraging advanced AI to <a href="https://benzinga.com/news/25/04/44678849/north-korean-it-workers-impersonating-americans-to-land-jobs-at-fortune-500-companies-to-fund-kim-jong-uns-weapons-program-report">alter </a>their appearances and voices and even managing to hold multiple jobs simultaneously, thereby increasing the amount of money funneled back to North Korea.
Furthermore, North Korean hackers infiltrated the U.S. corporate system to launch a malware campaign aimed at crypto developers. They set up fake companies using <a href="https://www.benzinga.com/content/44999851/north-korea-spies-used-fake-us-firms-to-hack-crypto-developers-report">fake names </a>and addresses in the US to carry out their operations.
Moreover, in March, North Korea, with the help of the infamous <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44349644/kim-jong-uns-north-korea-backed-lazarus-group-now-has-more-bitcoin-than-el-salvador">hacking syndicate</a> Lazarus Group, has quietly become one of the biggest holders of Bitcoin. The stash was valued at more than double the amount held by El Salvador, the well-known Bitcoin-friendly country.
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/25/05/45486095/bitcoin-breaks-107000-ethereum-dips-dogecoin-rallies-as-greed-sentiment-takes-over-analyst-predicts-great-6-8-week-period">Bitcoin Breaks $107,000, Ethereum Dips, Dogecoin Rallies As &#8216;Greed&#8217; Sentiment Takes Over: Analyst Predicts BTC &#8216;Primed&#8217; For A New All-Time High</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

News

Markets

Fortune 500 Companies Exploited To Fund North Korea's Nuclear Program Through Kim Jong Un's 'Mafia'-Style Cybercrime Operations: Report

<ul>
<li>Total revenues for the first quarter 2025 are estimated to be between RMB87.0 million and RMB90.0 million, representing year-over-year increase of approximately 35% to 40% compared with RMB64.5 million in the first quarter of 2024. &nbsp;</li>
<li>Net Loss for the first quarter 2025 is estimated to be between RMB1.0 million and RMB2.0 million, compared with RMB2.6 million in the first quarter of 2024. &nbsp;</li>
<li>Cash and cash equivalents and restricted cash as of March 31, 2025 are estimated to be between RMB113.0 million and RMB114.0 million as compared with RMB119.5 million as of December 31, 2024.</li>
</ul>

Guidance

Aurora Mobile Expects Q1 Revenue Of RMB87.0M-RMB90.0M, Up By 35%-40% YoY

ManpowerGroup Invests In France's Digital Future With AI HR Hub In La Défense, Supporting Macron's Choose France Vision

SKYE

Skye And Arecor Collaborate On High-Concentration Formulation Of CB1 Inhibitor Nimacimab To Improve Dosing And Patient Compliance

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it has commenced tender offers (the "Offers") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,000,000,000 (equivalent) (the "Total Maximum Amount") of the following series of notes issued by finance subsidiaries of Teva and guaranteed by Teva:
<ul>
<li>USD 3.150% Senior Notes due 2026, CUSIP 88167AAE1 / ISIN US88167AAE10 (Registered), issued by Teva Pharmaceutical Finance Netherlands III B.V. (the "Pool 1 Notes");</li>
<li>USD 4.750% Sustainability-Linked Senior Notes due 2027, CUSIP 88167AAP6 / ISIN US88167AAP66 (Registered), issued by Teva Pharmaceutical Finance Netherlands III B.V. (the "Priority 2 Notes");</li>
<li>EUR 3.750% Sustainability-Linked Senior Notes due 2027, Common Code 240660709 / ISIN XS2406607098 (Registered), issued by Teva Pharmaceutical Finance Netherlands II B.V. (the "Priority 3 Notes" and together with the Priority 2 Notes, the "Pool 2 Notes");</li>
<li>USD 7.875% Sustainability-Linked Senior Notes due 2029, CUSIP 88167AAS0 / ISIN US88167AAS06 (Registered), issued by Teva Pharmaceutical Finance Netherlands III B.V. (the "Priority 4 Notes");</li>
<li>EUR 7.375% Sustainability-Linked Senior Notes due 2029, Common Code 259280443 / ISIN XS2592804434 (Registered), issued by Teva Pharmaceutical Finance Netherlands II B.V. (the "Priority 5 Notes"); and</li>
<li>USD 8.125% Sustainability-Linked Senior Notes due 2031, CUSIP 88167AAR2 / ISIN US88167AAR23 (Registered), issued by Teva Pharmaceutical Finance Netherlands III B.V. (the "Priority 6 Notes," and together with the Priority 4 Notes and the Priority 5 Notes, the "Pool 3 Notes," and the Pool 3 Notes, together with the Pool 1 Notes and the Pool 2 Notes, the "Notes").</li>
</ul>

Buybacks

TEVA

Teva Launches $2 Billion Bond Buyback to Cut Debt Across Multiple Note Series

Macro Economic Events

Econ #s

Economics

Eurozone Consumer Price Index (YoY) For April 2.2% Vs. 2.2% Est.; 2.2% Prior

Eurozone Consumer Price Index (MoM) For April 0.6% Vs. 0.6% Est.; 0.6% Prior

Eurozone Core Consumer Price Index (YoY) For April 2.7% Vs. 2.7% Est.; 2.4% Prior

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) was trading lower Monday morning following an overnight spike that propelled it beyond $0.23.
What happened: The world's largest meme coin by market capitalization experienced a volatile day of trading, with volumes more than doubling to $2.84 billion in the last 24 hours.&nbsp;
DOGE broke past $0.23 twice on Sunday but was met with heavy resistance each time, leading to a U-turn. As of this writing, the cryptocurrency has retraced 8.7% from its intraday high and more than 3% in the last 24 hours.
DOGE followed in Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) footsteps, <a href="https://www.benzinga.com/25/05/45486095/bitcoin-breaks-107000-ethereum-dips-dogecoin-rallies-as-greed-sentiment-takes-over-analyst-predicts-great-6-8-week-period">which rallied sharply Sunday night and tapped $107,000 for the first time</a> in nearly four months.
Cryptocurrency trader and analyst Chandler predicted DOGE to "absolutely explode" when BTC hits a new high and holds above $110,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The moment <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> breaks ATH and holds above $110k, <a href="https://twitter.com/search?q=%24PEPE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PEPE</a> and <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> will absolutely explode. &#x1f438;&#x1f4c8; <a href="https://t.co/HeObtzryhH">pic.twitter.com/HeObtzryhH</a>
&mdash; Chandler&#x26a1;&#xFE0F; (@ChandlerCharts) <a href="https://twitter.com/ChandlerCharts/status/1924260196219560084?ref_src=twsrc%5Etfw">May 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45486943/arthur-hayes-forecasts-bitcoin-will-hit-200000-in-next-bull-run-anticipates-revival-of-fortunes-for-this-hated-coin">Arthur Hayes Forecasts Bitcoin Will Hit $200,000 In Next Bull Run, Anticipates Revival Of Fortunes For This &#8216;Hated&#8217; Coin</a>
Meanwhile, nearly 80% of derivatives traders on Binance with open DOGE positions were leveraged long, according to Coinglass, indicating a bullish outlook for the memecoin.
The Bull Bear Power indicator, which measures the strength of buyers and sellers, flashed a "Buy" signal for DOGE, <a href="https://in.tradingview.com/symbols/DOGEUSD/technicals/">according </a>to TradingView.&nbsp; However, the Momentum indicator, which compares the short-term price and long-term price, indicated &#8220;Sell.&#8221;&nbsp;
Price Action:&nbsp; At the time of writing, DOGE was exchanging hands at $0.2164, down 3.31% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, the coin has dived 31%.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45486583/michael-saylors-tip-to-grow-wealth-by-100x-dont-quit-jobs-invest-in-bitcoin-over-obscenely-expensive-items">Michael Saylor Has A Tip For Average People Looking To Grow Their Wealth By 100x, But He Doesn&#8217;t Want You To Quit Your Job To Invest In Bitcoin</a></li>
</ul>
Image Via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

Why Is Dogecoin Trading Lower On Monday Morning?

After Moody&#8217;s Ratings recently downgraded the United States&#8217; long-term credit rating, this expert has highlighted that the rating agency had an investment grade rating on the U.S. debt even ahead of the 2008 global financial crisis.
What Happened: Moody&#8217;s recently changed its <a href="https://www.benzinga.com/news/econ-s/25/05/45479078/moodys-downgrades-us-credit-rating-over-debt-deficit-concerns">rating from Aaa to Aa1</a> and shifted its outlook from &#8220;negative&#8221; to &#8220;stable.&#8221; This decision means the U.S. has now lost its top-tier &#8220;triple-A&#8221; rating from all three major credit agencies, following similar downgrades by Fitch and S&amp;P Global.
However, experts like Ryan Detrick, from Carson Research, offer a perspective of measured reaction. In a post on X, Detrick pointed out that Moody&#8217;s downgrade is not unprecedented, as other agencies have already taken similar action.
He also highlighted a historical context, noting, &#8220;Also, don&#8217;t forget the day Lehman went under (9/15/08), Moody&#8217;s had it rated A2.&#8221;
This suggests that even leading credit rating agencies can maintain relatively high ratings on entities shortly before significant financial distress. Detrick concluded that the recent downgrade by Moody&#8217;s should &#8220;not [be] a huge shock&#8221; given these factors.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Yes, Moody&#39;s cut US debt, but let&#39;s not forget others already have already done this. Not a huge shock. Also don&#39;t forget the day Lehman went under (9/15/08), Moody&#39;s had it rated A2. <a href="https://t.co/Hool1GugHh">pic.twitter.com/Hool1GugHh</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1923726194391797811?ref_src=twsrc%5Etfw">May 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/general/market-summary/25/05/45465955/ark-invest-takes-swipe-at-mstr-mara-says-bitcoin-treasury-companies-dont-make-sense-fundin">Ark Invest Expert Takes Swipe At MSTR, MARA, Says ‘Bitcoin Treasury Companies Don't Make Sense:' ‘Funding Purchases With Debt…Seems Like A Recipe For Disaster'</a>
Why It Matters: The agency cited a sustained increase in government debt and interest payment ratios over the past decade as the primary drivers for the downgrade.
Moody&#8217;s projects the U.S. debt-to-GDP ratio to rise from nearly 100% in 2025 to approximately 130% by 2035. In a statement released in late March, Moody&#8217;s noted that even under favorable economic conditions, the affordability of U.S. debt remains significantly weaker compared to other Aaa-rated and highly-rated sovereign nations.
Moody&#8217;s also pointed to the consistent failure of successive U.S. administrations and Congress to implement measures that would reverse large annual fiscal deficits and the increasing costs of interest payments.
The agency anticipates these trends will persist without substantial reductions in mandatory spending or deficits, leading to further increases in debt and interest burdens over the next decade.
&#8220;While we recognize the US&#8217; significant economic and financial strengths, we believe these no longer fully counterbalance the decline in fiscal metrics,&#8221; Moody&#8217;s stated on Friday, according <a href="https://www.bloomberg.com/news/articles/2025-05-16/us-credit-rating-cut-by-moody-s-on-government-debt-increase">to</a> Bloomberg. 
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, ended higher on Friday. The SPY was up 0.63% to $594.20, while the QQQ advanced 0.44% to $521.51, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Monday, the futures of the S&amp;P 500, Nasdaq 100, and Dow Jones were trading lower.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45433051/jim-cramer-says-gulf-countries-will-become-the-largest-hyperscalers-in-the-world-following-ai-deals">Jim Cramer Says Gulf Countries Will Become ‘Largest Hyperscalers In The World' After Nvidia's 18,000 Blackwell Chip Deal</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Andrius Zemaitis / Shutterstock.com

Market Summary

Analyst Ratings

Moody's Had An Investment Grade Rating On US Debt During 2008 Global Financial Crisis: Recent Cut 'Not A Huge Shock,' Says Expert

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions that increase the risk of severe illness.
What Happened: The decision follows a six-week delay during which regulators sought additional data about the protein-based vaccine, which differs from the mRNA technology used by Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>), <a href="https://edition.cnn.com/2025/05/17/health/novavax-covid-vaccine-approval">reported</a> CNN.
&#8220;This significant milestone demonstrates our commitment to these populations and is a significant step towards availability of our protein-based vaccine option,&#8221; Novavax President and CEO John Jacobs said in a statement Saturday.
The FDA is requiring Novavax to conduct postmarketing studies examining the risk of myocarditis and pericarditis—heart inflammation conditions rarely reported after COVID-19 vaccination. While a handful of cases were reported in trials, the CDC maintains that vaccination benefits outweigh these rare risks.
See Also: <a href="https://www.benzinga.com/markets/emerging-markets/25/05/45487876/america-must-shift-roles-from-world-police-to-world-gun-store-says-palmer-luckey">America Must Shift Roles From &#8216;World Police&#8217; To &#8216;World Gun Store,&#8217; Says Palmer Luckey</a>
Why It Matters: The approval comes amid shifting political winds at the FDA, where Commissioner Marty Makary previously characterized <a href="https://www.benzinga.com/general/health-care/25/04/45059756/trump-era-fda-appointees-request-new-trials-for-novavax-covid-vaccine-reportedly-delaying-approval-timeline?utm_source=chatgpt.com">updated COVID vaccines as &#8220;new products&#8221;</a> requiring fresh clinical trials. In April, Makary tweeted: &#8220;Under this administration, we are prioritizing the Gold Standard of Science—not what saves pharma.&#8221;
President Donald Trump administration appointees had directed a pause on Novavax&#8217;s application despite it being on track for approval by April 1, according to the Associated Press.
Earlier studies showed <a href="https://www.benzinga.com/general/biotech/25/04/44824383/novavax-covid-vaccine-shows-milder-side-effects-than-pfizer-biontechs-shot-study?utm_source=chatgpt.com">Novavax&#8217;s 2024-2025 formula </a>targeting the JN.1 strain produced fewer and less severe side effects compared to mRNA alternatives. In the SHIELD-Utah study, Novavax recipients experienced 1.7 symptoms on average versus 2.8 symptoms for Pfizer-BioNTech recipients.
The CDC&#8217;s vaccine advisers are currently considering changes to guidance for annual COVID-19 shots, potentially focusing recommendations on older adults, immunocompromised individuals, and those with higher exposure risks, the report noted.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45487788/trumps-drug-price-order-hits-pbms-hardest-cvs-cigna-unh-in-focus-as-experts-highlight-racket-and-pricing-distortion">Trump&#8217;s Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight &#8216;Racket,&#8217; Pricing Distortion</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Equities

Regulations

Health Care

BNTX

NVAX

Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny

General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) wants to overturn California's EV policy, which aims to phase out ICE vehicles by 2035.
What Happened: The mandate has already been adopted by 11 other states in the U.S. as the Detroit-based automaker cites slower-than-expected growth in the EV sector, the Wall Street Journal reported <a href="https://www.wsj.com/business/autos/california-ev-mandate-auto-industry-64708033">on</a> Sunday.
The report suggests the company sent an email to employees, reiterating the automaker's stance on the mandate. "Emissions standards that are not aligned with market realities pose a serious threat to our business by undermining consumer choice and vehicle affordability," GM said in the email.
EV sales in the U.S. have declined by over 5% in April as zero-emission vehicles make up over 20% of California's total sales, data cited in the report says. GM has also scaled back its EV production goals as demand declines, the report outlines.
Why It Matters: The news comes in as GM CEO Mary Barra had shared that the company expects a <a href="https://www.benzinga.com/25/05/45159130/general-motors-ceo-mary-barra-says-prices-will-remain-the-same-amid-donald-trumps-tariffs-that-could-cost-company-5-billion-dollars">$5 billion hit </a>in costs due to U.S. President Donald Trump's auto tariffs.
The company had also pulled its <a href="https://www.benzinga.com/news/guidance/25/05/45133096/this-is-how-much-it-will-cost-general-motors-from-trumps-tariff-policy">earnings guidance for 2025</a>, outlining the uncertainty currently faced by the automotive industry. The company recently criticized the Trump administration's <a href="https://www.benzinga.com/25/05/45314561/trumps-uk-trade-deal-draws-criticism-from-ford-gm-stellantis-this-hurts-american-automakers-suppliers-and-auto-workers">trade deal with the UK</a>.
"This hurts American automakers, suppliers, and auto workers," representatives of the company said in a statement.&nbsp;
Elsewhere, House GOP Representatives want to <a href="https://www.benzinga.com/tech/25/05/45277309/house-gop-representatives-want-to-axe-federal-ev-credit-amid-trumps-tax-cuts-report">axe the Federal EV credit </a>currently offered as an incentive to drive up EV adoption, casting more uncertainty over the sector.
Price Action: GM Stock gained 0.52% at close and currently trades for $50.37, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45447473/trump-says-tariff-money-could-replace-the-income-tax-april-customs-collections-hit-record-15-4-billion-as-new-duties-take-effect">Trump Says Tariff Money Could &#8216;Replace The Income Tax&#8217; — April Customs Collections Hit Record $15.4 Billion As New Duties Take Effect</a></li>
</ul>
Photo courtesy: Jonathan Weiss / Shutterstock.com

Tech

General

General Motors Wants To Overturn California's EV Mandate As Demand Slows In The US: Report

<h3>Companies Reporting Before The Bell</h3>
• Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is estimated to report quarterly earnings at $2.33 per share on revenue of $172.23 million. 
• Niu Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) is expected to report earnings for its first quarter. 
• ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $1.77 billion. 
• Sohu.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHU#NASDAQ">SOHU</a>) is projected to report earnings for its first quarter. 
• Gilat Satellite Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILT#NASDAQ">GILT</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $100.20 million. 
• ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $1.84 billion. 
• Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) is expected to report quarterly loss at $0.02 per share on revenue of $65.37 million. 
• Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) is estimated to report earnings for its first quarter. 
• CBAK Energy Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAT#NASDAQ">CBAT</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $52.16 million. 
• Oxford Lane Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLC#NASDAQ">OXLC</a>) is likely to report quarterly earnings at $0.28 per share on revenue of $115.00 million. 
• Compugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEN#NASDAQ">CGEN</a>) is likely to report quarterly loss at $0.05 per share on revenue of $3.70 million. 
<h3>Companies Reporting After The Bell</h3>
• Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $81.80 million. 
• Safe Bulkers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SB#NYSE">SB</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $57.92 million. 
• 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $177.98 million. 
• TAT Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $42.59 million. 
• Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is expected to report earnings for its first quarter. 
• Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is projected to report quarterly earnings at $1.72 per share on revenue of $615.60 million. 
• Transcat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) is estimated to report quarterly earnings at $0.62 per share on revenue of $76.40 million. 
• Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) is estimated to report quarterly earnings at $0.86 per share on revenue of $1.91 billion. 
• Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) is projected to report quarterly earnings at $0.29 per share on revenue of $71.42 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AGYS

CBAT

CGEN

EGHT

GILT

OXLC

QFIN

SOHU

TATT

TCOM

TRNR

TRNS

YALA

ZEPP

Earnings Scheduled For May 19, 2025

ERIC

Ericsson To Sell Up To 60% Of Vested LTV 2022 Shares To Settle Withholding Taxes And Social Security Costs

Vertiv Accelerates AI Data Center Evolution With High-Efficiency 800 VDC Solutions Aligned To NVIDIA's Future AI Roadmap

NVDA

HPE Expands NVIDIA Collaboration With AI Factory-Ready Cloud, Storage, And Compute Platforms Featuring RTX PRO 6000 Blackwell GPU Support

NTAP

NetApp Integrates NVIDIA AI Data Platform Into AIPod To Accelerate Agentic AI And Retrieval-Augmented Generation

SMCI

Supermicro Expands AI Portfolio With RTX PRO 6000 Blackwell Systems, Supporting NVIDIA Enterprise AI Factory Validated Designs

Former Vice President&nbsp;Mike Pence&nbsp;has lauded&nbsp;President Donald Trump&#8216;s Middle East visit for its beneficial effects on the U.S. economy, despite his criticism of the diplomatic aspects of the trip. 
What Happened:&nbsp;&nbsp;Despite a public fallout with Trump over the&nbsp;2020 presidential election certification and the ensuing Capitol riot on January 6, 2021, Pence spoke positively of Trump&#8217;s Middle East trip&#8217;s impact on the American economy during an NBC&#8217;s &#8220;Meet the Press&#8221; interview on Sunday. 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Exclusive Interview: Mike Pence says he privately warned Trump against tariffs in his first term" width="500" height="281" src="https://www.youtube.com/embed/LzCiUDJyYAw?start=524&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Pence described the journey as &#8220;very successful&#8221; for the U.S. economy. &#8220;The&nbsp;president secured financial commitments in&nbsp;all three countries, including a&nbsp;historic contract for purchasing Boeing&nbsp;aircraft that&#8217;ll really support American jobs,&#8221; Pence said.
These comments from the former Indiana governor are noteworthy, given his recent strained relationship with Trump and recent criticisms of the President&#8217;s <a href="https://www.benzinga.com/news/25/05/45214328/mike-pence-warns-trumps-indiscriminate-tariffs-could-trigger-price-shock-and-potential-shortages-keeping-our-kids-toys-affordable-is-part-of-the-american-dream">sweeping tariffs</a>.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/equities/25/05/45486452/jim-cramer-recalls-2011s-6-7-market-decline-after-us-debt-downgrade-says-it-ultimately-meant-not" target="_blank" rel="noreferrer noopener">Jim Cramer Recalls 2011&#8217;s 6.7% Market Decline After US Debt Downgrade, Says It &#8216;Ultimately Meant Nothing:&#8217; Dan Niles Sees Limited Downside Amid Tariff Rollbacks, FOMO</a>
Why It Matters: Trump&#8217;s Middle East visit, which Pence praises, saw the signing of deals worth <a href="https://www.benzinga.com/25/05/45462404/trump-unveils-over-200-billion-worth-of-deals-with-uae-including-major-etihad-airways-commitment">over $200 billion </a>between the U.S. and the United Arab Emirates (UAE). A significant part of these deals involved a $14.5 billion commitment from&nbsp;Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>),&nbsp;GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), and Etihad Airways. 
Additionally, Trump secured a $1.2 trillion economic agreement with Qatar, including a <a href="https://www.benzinga.com/government/regulations/25/05/45446924/trump-secures-12-trillion-qatar-deal-as-boeing-ge-land-record-orders">record-breaking</a> $96 billion order from Qatar Airways for Boeing and GE Aerospace.
According to CNN, several Democrats, usually critical of President Trump, praised his decision to lift longstanding sanctions on Syria and engage with its new leader. They saw it as a potential economic boost for Syria and a way to reshape the region. Support came from figures like Leon Panetta, Rep. Jim Himes (D-Conn.) and Sen. Chris Murphy (D-Conn.), with Himes reluctantly admitting Trump managed much of the Middle East trip effectively. Murphy, however, criticized Trump for accepting the luxury Qatari jet.
On the other hand, economist Peter Schiff warned that Qatar&#8217;s $200 billion deal with Boeing <a href="https://www.benzinga.com/general/travel/25/05/45427289/peter-schiff-warns-qatars-200-billion-boeing-deal-could-spike-us-inflation-interest-rates-says-treasury-sell-off-may-follow">could lead </a>to a surge in U.S. inflation and interest rates. He states that to help finance the purchase, "Qatar will likely sell a lot of Treasuries and other U.S. assets," which would further strain the U.S. bond market, already under pressure.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/tech/25/05/45485055/elon-musks-ex-girlfriend-grimes-questions-mark-zuckerbergs-aptitude-for-metaverse-leadership-says-zuckerberg" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s Ex-Girlfriend Grimes Questions Mark Zuckerberg&#8217;s Aptitude For Metaverse Leadership, Says Zuckerberg Is &#8216;Wildly Under Qualified&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump's Middle East Trip Draws Rare Praise From Mike Pence As 'Very Successful' For US Economy Amid 'Historic' Boeing Deal: 'That'll Really Support American Jobs'

CRWD

CrowdStrike And NVIDIA Partner To Secure Full AI Lifecycle With Integrated Falcon Platform In Enterprise AI Factory Deployments

Press Releases

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Management

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Comments

Fortress Biotech

ニュース

パートナーシップ

ベンジンガ・グローバル